Review Article
Hypertension May Reduce the Infection Risk but Increase the Severity of COVID-19: Based on the Current Data in China
Figure 6
(a) Prevalence of usage of ACEIs/ARBs in COVID-19 patients with hypertension. (b) Comparison of mortality in ACEI/ARB and non-ACEI/ARB patients. (c) Comparison of the incidences of the severe/ICU rate in ACEI/ARB and non-ACEI/ARB patients.
(a) |
(b) |
(c) |